Litcius/Paper detail

Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Sara Saberi, Theodore P. Abraham, Lubna Choudhury, Roberto Barriales‐Villa, Perry Elliott, Michael E. Nassif, Artur Oręziak, Anjali Owens, Albree Tower‐Rader, Florian Rader, Pablo García‐Pavía, Iacopo Olivotto, Caroline Coats, Michael A. Fifer, Mark V. Sherrid, Scott D. Solomon, Hugh Watkins, Stephen B. Heitner, Daniel Jacoby, Stuart Kupfer, Fady I. Malik, Chiara Melloni, Lisa Meng, Jenny Wei, Martin S. Maron, Ahmad Masri

2025JACC Heart Failure18 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHypertrophic cardiomyopathyCardiologyInternal medicineEjection fractionVentricular outflow tractTolerabilityHeart failurePlaceboCardiomyopathyAdverse effectAlternative medicinePathologyCardiomyopathy and Myosin StudiesCardiovascular Function and Risk FactorsCardiac Fibrosis and Remodeling
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy | Litcius